HEADER HYDROLASE 29-AUG-04 1W75 TITLE NATIVE ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE TITLE 2 (ACHE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLCHOLINESTERASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 22-564; COMPND 5 SYNONYM: ACHE; COMPND 6 EC: 3.1.1.7 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TORPEDO CALIFORNICA; SOURCE 3 ORGANISM_COMMON: PACIFIC ELECTRIC RAY; SOURCE 4 ORGANISM_TAXID: 7787; SOURCE 5 VARIANT: G2 FORM; SOURCE 6 ORGAN: ELECTRIC ORGAN; SOURCE 7 TISSUE: ELECTROPLAQUE KEYWDS ALZHEIMER'S DISEASE, CHOLINESTERASE, GLYCOPROTEIN, GPI- ANCHOR, KEYWDS 2 HYDROLASE, MUSCLE, NERVE, NEUROTRANSMITTER DEGRADATION, SERINE KEYWDS 3 ESTERASE, SERINE HYDROLASE, SYNAPSE EXPDTA X-RAY DIFFRACTION AUTHOR H.M.GREENBLATT,S.BOTTI,A.ARGAMAN,I.SILMAN,J.L.SUSSMAN REVDAT 5 29-JUL-20 1W75 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 10-APR-19 1W75 1 JRNL LINK REVDAT 3 13-JUL-11 1W75 1 VERSN REVDAT 2 24-FEB-09 1W75 1 VERSN REVDAT 1 25-NOV-04 1W75 0 JRNL AUTH H.M.GREENBLATT,C.GUILLOU,D.GUENARD,A.ARGAMAN,S.BOTTI, JRNL AUTH 2 B.BADET,C.THAL,I.SILMAN,J.L.SUSSMAN JRNL TITL THE COMPLEX OF A BIVALENT DERIVATIVE OF GALANTHAMINE WITH JRNL TITL 2 TORPEDO ACETYLCHOLINESTERASE DISPLAYS DRASTIC DEFORMATION OF JRNL TITL 3 THE ACTIVE-SITE GORGE: IMPLICATIONS FOR STRUCTURE-BASED DRUG JRNL TITL 4 DESIGN. JRNL REF J.AM.CHEM.SOC. V. 126 15405 2004 JRNL REFN ISSN 0002-7863 JRNL PMID 15563167 JRNL DOI 10.1021/JA0466154 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.MARY,D.Z.RENKO,C.GUILLOU,C.THAL REMARK 1 TITL POTENT ACETYLCHOLINESTERASE INHIBITORS: DESIGN, SYNTHESIS, REMARK 1 TITL 2 AND STRUCTURE-ACTIVITY RELATIONSHIPS OF BIS-INTERACTING REMARK 1 TITL 3 LIGANDS IN THE GALANTHAMINE SERIES REMARK 1 REF BIOORG.MED.CHEM. V. 6 1835 1998 REMARK 1 REFN ISSN 0968-0896 REMARK 1 PMID 9839013 REMARK 1 DOI 10.1016/S0968-0896(98)00133-3 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 52293 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 2715 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3583 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2600 REMARK 3 BIN FREE R VALUE SET COUNT : 181 REMARK 3 BIN FREE R VALUE : 0.3070 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8369 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 252 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 42.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.87 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.41900 REMARK 3 B22 (A**2) : 6.40400 REMARK 3 B33 (A**2) : -3.98500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.357 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.250 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.180 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.803 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8679 ; 0.015 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11796 ; 1.562 ; 1.944 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1057 ; 6.675 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1252 ; 0.118 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6684 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4036 ; 0.221 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 5953 ; 0.317 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 427 ; 0.128 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 14 ; 0.200 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.276 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5273 ; 0.694 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8513 ; 1.340 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3406 ; 2.135 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3283 ; 3.385 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 4 A 535 REMARK 3 ORIGIN FOR THE GROUP (A): 85.6010 51.5170 21.1630 REMARK 3 T TENSOR REMARK 3 T11: 0.0485 T22: 0.0104 REMARK 3 T33: 0.0485 T12: 0.0002 REMARK 3 T13: -0.0039 T23: 0.0223 REMARK 3 L TENSOR REMARK 3 L11: 0.0994 L22: 0.0436 REMARK 3 L33: 0.2201 L12: -0.0220 REMARK 3 L13: 0.0198 L23: -0.0495 REMARK 3 S TENSOR REMARK 3 S11: 0.0030 S12: 0.0001 S13: 0.0014 REMARK 3 S21: -0.0054 S22: 0.0041 S23: 0.0100 REMARK 3 S31: 0.0159 S32: 0.0003 S33: -0.0072 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 4 B 535 REMARK 3 ORIGIN FOR THE GROUP (A): 97.3340 50.6020 81.5520 REMARK 3 T TENSOR REMARK 3 T11: 0.0492 T22: 0.0158 REMARK 3 T33: 0.0439 T12: 0.0033 REMARK 3 T13: -0.0021 T23: -0.0188 REMARK 3 L TENSOR REMARK 3 L11: 0.1515 L22: 0.0249 REMARK 3 L33: 0.1550 L12: 0.0015 REMARK 3 L13: 0.0245 L23: 0.0330 REMARK 3 S TENSOR REMARK 3 S11: -0.0095 S12: -0.0093 S13: 0.0144 REMARK 3 S21: 0.0019 S22: 0.0156 S23: -0.0004 REMARK 3 S31: 0.0035 S32: 0.0073 S33: -0.0060 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL PLUS MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. THE TWO MOLECULES IN THE ASYMMETRIC UNIT ARE RELATED REMARK 3 BY A NON-CRYSTALLOGRAPHIC TWO FOLD AXIS. NCS WAS NOT USED IN REMARK 3 REFINEMENT. THE RESIDUES BETWEEN 485-490 ARE MISSING IN CHAIN A REMARK 3 AND FIT IN CHAIN B. REMARK 4 REMARK 4 1W75 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-AUG-04. REMARK 100 THE DEPOSITION ID IS D_1290020887. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-03 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC BLUE REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU IMAGE PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55093 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.27000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN IN 100MM NACL, 0.01%NAN3, 1MM REMARK 280 MES PH6.5, MIXED 1/1 WITH SOLUBILIZED LI5 (PW11O39RHCH2COOH), 3 REMARK 280 MICROLITER OF THIS MIXTURE WAS MIXED WITH 3 MICROLITER OF 40% REMARK 280 PEG200 IN 0.5M MES PH5.8, SUSPENDED OVER WELL WITH 36%PEG200 IN REMARK 280 0.5M MES, PH 5.8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 45.75100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.17150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.29300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.17150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 45.75100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.29300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ASP A 2 REMARK 465 HIS A 3 REMARK 465 HIS A 486 REMARK 465 SER A 487 REMARK 465 GLN A 488 REMARK 465 GLU A 489 REMARK 465 ALA A 536 REMARK 465 CYS A 537 REMARK 465 ASP A 538 REMARK 465 GLY A 539 REMARK 465 GLU A 540 REMARK 465 LEU A 541 REMARK 465 SER A 542 REMARK 465 SER A 543 REMARK 465 ASP B 1 REMARK 465 ASP B 2 REMARK 465 HIS B 3 REMARK 465 ALA B 536 REMARK 465 CYS B 537 REMARK 465 ASP B 538 REMARK 465 GLY B 539 REMARK 465 GLU B 540 REMARK 465 LEU B 541 REMARK 465 SER B 542 REMARK 465 SER B 543 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 46 CZ NH1 NH2 REMARK 470 LYS A 52 CE NZ REMARK 470 GLU A 89 CD OE1 OE2 REMARK 470 ARG A 250 CZ NH1 NH2 REMARK 470 ASN A 257 CG OD1 ND2 REMARK 470 GLU A 260 CD OE1 OE2 REMARK 470 GLU A 268 OE1 OE2 REMARK 470 GLU A 344 OE1 OE2 REMARK 470 GLU A 350 OE1 OE2 REMARK 470 LYS A 357 NZ REMARK 470 LYS A 413 CD CE NZ REMARK 470 LYS A 454 CD CE NZ REMARK 470 LYS A 498 CG CD CE NZ REMARK 470 GLU A 508 CD OE1 OE2 REMARK 470 LYS A 511 CD CE NZ REMARK 470 ARG A 515 CZ NH1 NH2 REMARK 470 GLN A 526 OE1 NE2 REMARK 470 ASN B 42 CG OD1 ND2 REMARK 470 ARG B 46 CZ NH1 NH2 REMARK 470 LYS B 192 CE NZ REMARK 470 ARG B 250 CZ NH1 NH2 REMARK 470 ASN B 257 CG OD1 ND2 REMARK 470 GLU B 260 OE1 OE2 REMARK 470 GLU B 268 OE1 OE2 REMARK 470 GLU B 350 OE1 OE2 REMARK 470 ASP B 365 OD1 OD2 REMARK 470 LYS B 413 CD CE NZ REMARK 470 GLN B 488 CG CD OE1 NE2 REMARK 470 GLU B 489 CG CD OE1 OE2 REMARK 470 LYS B 498 CE NZ REMARK 470 ARG B 515 CZ NH1 NH2 REMARK 470 GLN B 526 OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 397 CB - CG - OD2 ANGL. DEV. = 7.5 DEGREES REMARK 500 VAL A 518 CB - CA - C ANGL. DEV. = -14.1 DEGREES REMARK 500 LEU A 531 CA - CB - CG ANGL. DEV. = 16.1 DEGREES REMARK 500 ASP B 217 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP B 297 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 23 64.37 34.76 REMARK 500 SER A 24 87.85 45.24 REMARK 500 SER A 25 170.15 142.30 REMARK 500 PHE A 45 -12.90 82.76 REMARK 500 ALA A 60 52.24 -105.70 REMARK 500 PHE A 120 -0.27 68.13 REMARK 500 SER A 200 -114.15 60.68 REMARK 500 GLU A 299 -77.39 -116.00 REMARK 500 ASP A 380 45.77 -145.05 REMARK 500 VAL A 400 -60.51 -124.49 REMARK 500 ASN A 424 31.82 -140.72 REMARK 500 GLN A 526 -51.91 -122.96 REMARK 500 SER B 25 -159.00 -142.68 REMARK 500 PHE B 45 -22.29 85.64 REMARK 500 ALA B 60 55.05 -109.21 REMARK 500 SER B 108 88.14 -158.56 REMARK 500 LEU B 158 76.68 -108.58 REMARK 500 SER B 200 -120.02 63.94 REMARK 500 ASN B 253 68.18 61.27 REMARK 500 GLU B 299 -65.25 -126.00 REMARK 500 ASP B 380 48.96 -154.68 REMARK 500 VAL B 400 -62.70 -125.53 REMARK 500 PRO B 451 -9.16 -59.56 REMARK 500 HIS B 486 15.15 58.82 REMARK 500 ASN B 506 -168.84 -160.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ACJ RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH TACRINE REMARK 900 RELATED ID: 1ACL RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH DECAMETHONIUM REMARK 900 RELATED ID: 1AMN RELATED DB: PDB REMARK 900 TRANSITION STATE ANALOG: ACETYLCHOLINESTERASE COMPLEXED WITH M-(N,N, REMARK 900 N-TRIMETHYLAMMONIO) TRIFLUOROACETOPHENONE REMARK 900 RELATED ID: 1AX9 RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, LAUE DATA REMARK 900 RELATED ID: 1CFJ RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REMARK 900 REACTION WITH O- ISOPROPYLMETHYLPHOSPHONOFLUORIDATE (GB, SARIN) REMARK 900 RELATED ID: 1DX6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-GALANTHAMINE REMARK 900 AT 2.3A RESOLUTION REMARK 900 RELATED ID: 1E3Q RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH BW284C51 REMARK 900 RELATED ID: 1E66 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH (-)-HUPRINE X AT REMARK 900 2.1A RESOLUTION REMARK 900 RELATED ID: 1EA5 RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE (E.C. 3.1.1.7 ) FROM TORPEDO REMARK 900 CALIFORNICA AT 1.8A RESOLUTION REMARK 900 RELATED ID: 1EEA RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1EVE RELATED DB: PDB REMARK 900 THREE DIMENSIONAL STRUCTURE OF THE ANTI- ALZHEIMER DRUG, E2020 REMARK 900 (ARICEPT), COMPLEXED WITH ITS TARGET ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1FSS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN- II REMARK 900 RELATED ID: 1GPK RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXE WITH (+)-HUPERZINE A AT REMARK 900 2.1A RESOLUTION REMARK 900 RELATED ID: 1GPN RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE B AT REMARK 900 2.35A RESOLUTION REMARK 900 RELATED ID: 1GQR RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH RIVASTIGMINE REMARK 900 RELATED ID: 1GQS RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH NAP REMARK 900 RELATED ID: 1H22 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH (S, REMARK 900 S)-(-)-BIS(10)- HUPERZINE A-LIKE INHIBITOR AT 2.15A RESOLUTION REMARK 900 RELATED ID: 1H23 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH (S, REMARK 900 S)-(-)-BIS(12)- HUPERZINE A-LIKE INHIBITOR AT 2.15A RESOLUTION REMARK 900 RELATED ID: 1HBJ RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF COMPLEX BETWEEN TORPEDO CALIFORNICA ACHE REMARK 900 AND A REVERSIBLE INHIBITOR, 4-AMINO-5-FLUORO-2-METHYL-3-( 3- REMARK 900 TRIFLUOROACETYLBENZYLTHIOMETHYL)QUINOLINE REMARK 900 RELATED ID: 1JGA RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,7- HEPTYLENE-BIS-N,N'-SYN-2- REMARK 900 PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 1JGB RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE DIISOPROPYLPHOSPHORYL- REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH 1,3- PROPYLENE-BIS-N,N'-SYN-4- REMARK 900 PYRIDINIUMALDOXIME REMARK 900 RELATED ID: 1JJB RELATED DB: PDB REMARK 900 A NEUTRAL MOLECULE IN CATION-BINDING SITE: SPECIFIC BINDINGOF PEG- REMARK 900 SH TO ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA REMARK 900 RELATED ID: 1OCE RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH MF268 REMARK 900 RELATED ID: 1ODC RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH N- REMARK 900 4'-QUINOLYL-N'-9 "-(1",2",3",4"-TETRAHYDROACRIDINYL)-1,8- REMARK 900 DIAMINOOCTANE AT 2.2A RESOLUTION REMARK 900 RELATED ID: 1QID RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 A) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIE RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 B) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIF RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 C) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIG RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 D) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIH RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 E) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QII RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 F) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIJ RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 G) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIK RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 H) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QIM RELATED DB: PDB REMARK 900 SPECIFIC CHEMICAL AND STRUCTURAL DAMAGE AT NINE TIME POINTS (POINT REMARK 900 I) CAUSED BY INTENSE SYNCHROTRON RADIATION TO TORPEDO CALIFORNICA REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1QTI RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 1SOM RELATED DB: PDB REMARK 900 TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED BY NERVE AGENT REMARK 900 GD (SOMAN). REMARK 900 RELATED ID: 1UT6 RELATED DB: PDB REMARK 900 STRUCTURE OF ACETYLCHOLINESTERASE (E.C. 3.1 .1.7) COMPLEXED WITH N- REMARK 900 9-(1',2',3',4 '-TETRAHYDROACRIDINYL)-1,8- DIAMINOOCTANE AT 2.4 REMARK 900 ANGSTROMS RESOLUTION. REMARK 900 RELATED ID: 1VOT RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH HUPERZINE A REMARK 900 RELATED ID: 1VXO RELATED DB: PDB REMARK 900 METHYLPHOSPHONYLATED ACETYLCHOLINESTERASE (AGED) OBTAINED BY REMARK 900 REACTION WITH O-ETHYL-S-[2-[ BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 1VXR RELATED DB: PDB REMARK 900 O-ETHYLMETHYLPHOSPHONYLATED ACETYLCHOLINESTERASE OBTAINED BY REMARK 900 REACTION WITH O-ETHYL-S-[2-[ BIS(1-METHYLETHYL) AMINO]ETHYL] REMARK 900 METHYLPHOSPHONOTHIOATE (VX) REMARK 900 RELATED ID: 1W4L RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH BIS-ACTING GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1W6R RELATED DB: PDB REMARK 900 COMPLEX OF TCACHE WITH GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 1W76 RELATED DB: PDB REMARK 900 ORTHORHOMBIC FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE (ACHE) REMARK 900 COMPLEXED WITH BIS- ACTING GALANTHAMINE DERIVATIVE REMARK 900 RELATED ID: 2ACE RELATED DB: PDB REMARK 900 NATIVE ACETYLCHOLINESTERASE FROM TORPEDO CALIFORNICA REMARK 900 RELATED ID: 2ACK RELATED DB: PDB REMARK 900 ACETYLCHOLINESTERASE COMPLEXED WITH EDROPHONIUM, MONOCHROMATIC DATA REMARK 900 RELATED ID: 2DFP RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF AGED DI-ISOPROPYL- PHOSPHORO-FLUORIDATE (DFP) REMARK 900 BOUND TO ACETYLCHOLINESTERASE REMARK 900 RELATED ID: 3ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (R)-E2020 BOUND ACETYLCHOLINESTERASE COMPLEX, REMARK 900 3 STRUCTURES REMARK 900 RELATED ID: 4ACE RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF (S)-E2020 BOUND ACETYLCHOLINESTERASE COMPLEX, REMARK 900 3 STRUCTURES REMARK 999 REMARK 999 SEQUENCE REMARK 999 THREE N-TERMINAL RESIDUES AND 8 C-TERMINAL RESIDUES NOT REMARK 999 SEEN IN DENSITY, AND NOT INCLUDED IN COORDINATE FILE. REMARK 999 RESIDUES 486-489 HAVE POOR DENSITY, AND ARE NOT MODELED. DBREF 1W75 A 1 543 UNP P04058 ACES_TORCA 22 564 DBREF 1W75 B 1 543 UNP P04058 ACES_TORCA 22 564 SEQRES 1 A 543 ASP ASP HIS SER GLU LEU LEU VAL ASN THR LYS SER GLY SEQRES 2 A 543 LYS VAL MET GLY THR ARG VAL PRO VAL LEU SER SER HIS SEQRES 3 A 543 ILE SER ALA PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO SEQRES 4 A 543 VAL GLY ASN MET ARG PHE ARG ARG PRO GLU PRO LYS LYS SEQRES 5 A 543 PRO TRP SER GLY VAL TRP ASN ALA SER THR TYR PRO ASN SEQRES 6 A 543 ASN CYS GLN GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE SEQRES 7 A 543 SER GLY SER GLU MET TRP ASN PRO ASN ARG GLU MET SER SEQRES 8 A 543 GLU ASP CYS LEU TYR LEU ASN ILE TRP VAL PRO SER PRO SEQRES 9 A 543 ARG PRO LYS SER THR THR VAL MET VAL TRP ILE TYR GLY SEQRES 10 A 543 GLY GLY PHE TYR SER GLY SER SER THR LEU ASP VAL TYR SEQRES 11 A 543 ASN GLY LYS TYR LEU ALA TYR THR GLU GLU VAL VAL LEU SEQRES 12 A 543 VAL SER LEU SER TYR ARG VAL GLY ALA PHE GLY PHE LEU SEQRES 13 A 543 ALA LEU HIS GLY SER GLN GLU ALA PRO GLY ASN VAL GLY SEQRES 14 A 543 LEU LEU ASP GLN ARG MET ALA LEU GLN TRP VAL HIS ASP SEQRES 15 A 543 ASN ILE GLN PHE PHE GLY GLY ASP PRO LYS THR VAL THR SEQRES 16 A 543 ILE PHE GLY GLU SER ALA GLY GLY ALA SER VAL GLY MET SEQRES 17 A 543 HIS ILE LEU SER PRO GLY SER ARG ASP LEU PHE ARG ARG SEQRES 18 A 543 ALA ILE LEU GLN SER GLY SER PRO ASN CYS PRO TRP ALA SEQRES 19 A 543 SER VAL SER VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU SEQRES 20 A 543 LEU GLY ARG ASN LEU ASN CYS ASN LEU ASN SER ASP GLU SEQRES 21 A 543 GLU LEU ILE HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU SEQRES 22 A 543 LEU ILE ASP VAL GLU TRP ASN VAL LEU PRO PHE ASP SER SEQRES 23 A 543 ILE PHE ARG PHE SER PHE VAL PRO VAL ILE ASP GLY GLU SEQRES 24 A 543 PHE PHE PRO THR SER LEU GLU SER MET LEU ASN SER GLY SEQRES 25 A 543 ASN PHE LYS LYS THR GLN ILE LEU LEU GLY VAL ASN LYS SEQRES 26 A 543 ASP GLU GLY SER PHE PHE LEU LEU TYR GLY ALA PRO GLY SEQRES 27 A 543 PHE SER LYS ASP SER GLU SER LYS ILE SER ARG GLU ASP SEQRES 28 A 543 PHE MET SER GLY VAL LYS LEU SER VAL PRO HIS ALA ASN SEQRES 29 A 543 ASP LEU GLY LEU ASP ALA VAL THR LEU GLN TYR THR ASP SEQRES 30 A 543 TRP MET ASP ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY SEQRES 31 A 543 LEU ASP ASP ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO SEQRES 32 A 543 LEU MET HIS PHE VAL ASN LYS TYR THR LYS PHE GLY ASN SEQRES 33 A 543 GLY THR TYR LEU TYR PHE PHE ASN HIS ARG ALA SER ASN SEQRES 34 A 543 LEU VAL TRP PRO GLU TRP MET GLY VAL ILE HIS GLY TYR SEQRES 35 A 543 GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU SEQRES 36 A 543 LEU ASN TYR THR ALA GLU GLU GLU ALA LEU SER ARG ARG SEQRES 37 A 543 ILE MET HIS TYR TRP ALA THR PHE ALA LYS THR GLY ASN SEQRES 38 A 543 PRO ASN GLU PRO HIS SER GLN GLU SER LYS TRP PRO LEU SEQRES 39 A 543 PHE THR THR LYS GLU GLN LYS PHE ILE ASP LEU ASN THR SEQRES 40 A 543 GLU PRO MET LYS VAL HIS GLN ARG LEU ARG VAL GLN MET SEQRES 41 A 543 CYS VAL PHE TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN SEQRES 42 A 543 ALA THR ALA CYS ASP GLY GLU LEU SER SER SEQRES 1 B 543 ASP ASP HIS SER GLU LEU LEU VAL ASN THR LYS SER GLY SEQRES 2 B 543 LYS VAL MET GLY THR ARG VAL PRO VAL LEU SER SER HIS SEQRES 3 B 543 ILE SER ALA PHE LEU GLY ILE PRO PHE ALA GLU PRO PRO SEQRES 4 B 543 VAL GLY ASN MET ARG PHE ARG ARG PRO GLU PRO LYS LYS SEQRES 5 B 543 PRO TRP SER GLY VAL TRP ASN ALA SER THR TYR PRO ASN SEQRES 6 B 543 ASN CYS GLN GLN TYR VAL ASP GLU GLN PHE PRO GLY PHE SEQRES 7 B 543 SER GLY SER GLU MET TRP ASN PRO ASN ARG GLU MET SER SEQRES 8 B 543 GLU ASP CYS LEU TYR LEU ASN ILE TRP VAL PRO SER PRO SEQRES 9 B 543 ARG PRO LYS SER THR THR VAL MET VAL TRP ILE TYR GLY SEQRES 10 B 543 GLY GLY PHE TYR SER GLY SER SER THR LEU ASP VAL TYR SEQRES 11 B 543 ASN GLY LYS TYR LEU ALA TYR THR GLU GLU VAL VAL LEU SEQRES 12 B 543 VAL SER LEU SER TYR ARG VAL GLY ALA PHE GLY PHE LEU SEQRES 13 B 543 ALA LEU HIS GLY SER GLN GLU ALA PRO GLY ASN VAL GLY SEQRES 14 B 543 LEU LEU ASP GLN ARG MET ALA LEU GLN TRP VAL HIS ASP SEQRES 15 B 543 ASN ILE GLN PHE PHE GLY GLY ASP PRO LYS THR VAL THR SEQRES 16 B 543 ILE PHE GLY GLU SER ALA GLY GLY ALA SER VAL GLY MET SEQRES 17 B 543 HIS ILE LEU SER PRO GLY SER ARG ASP LEU PHE ARG ARG SEQRES 18 B 543 ALA ILE LEU GLN SER GLY SER PRO ASN CYS PRO TRP ALA SEQRES 19 B 543 SER VAL SER VAL ALA GLU GLY ARG ARG ARG ALA VAL GLU SEQRES 20 B 543 LEU GLY ARG ASN LEU ASN CYS ASN LEU ASN SER ASP GLU SEQRES 21 B 543 GLU LEU ILE HIS CYS LEU ARG GLU LYS LYS PRO GLN GLU SEQRES 22 B 543 LEU ILE ASP VAL GLU TRP ASN VAL LEU PRO PHE ASP SER SEQRES 23 B 543 ILE PHE ARG PHE SER PHE VAL PRO VAL ILE ASP GLY GLU SEQRES 24 B 543 PHE PHE PRO THR SER LEU GLU SER MET LEU ASN SER GLY SEQRES 25 B 543 ASN PHE LYS LYS THR GLN ILE LEU LEU GLY VAL ASN LYS SEQRES 26 B 543 ASP GLU GLY SER PHE PHE LEU LEU TYR GLY ALA PRO GLY SEQRES 27 B 543 PHE SER LYS ASP SER GLU SER LYS ILE SER ARG GLU ASP SEQRES 28 B 543 PHE MET SER GLY VAL LYS LEU SER VAL PRO HIS ALA ASN SEQRES 29 B 543 ASP LEU GLY LEU ASP ALA VAL THR LEU GLN TYR THR ASP SEQRES 30 B 543 TRP MET ASP ASP ASN ASN GLY ILE LYS ASN ARG ASP GLY SEQRES 31 B 543 LEU ASP ASP ILE VAL GLY ASP HIS ASN VAL ILE CYS PRO SEQRES 32 B 543 LEU MET HIS PHE VAL ASN LYS TYR THR LYS PHE GLY ASN SEQRES 33 B 543 GLY THR TYR LEU TYR PHE PHE ASN HIS ARG ALA SER ASN SEQRES 34 B 543 LEU VAL TRP PRO GLU TRP MET GLY VAL ILE HIS GLY TYR SEQRES 35 B 543 GLU ILE GLU PHE VAL PHE GLY LEU PRO LEU VAL LYS GLU SEQRES 36 B 543 LEU ASN TYR THR ALA GLU GLU GLU ALA LEU SER ARG ARG SEQRES 37 B 543 ILE MET HIS TYR TRP ALA THR PHE ALA LYS THR GLY ASN SEQRES 38 B 543 PRO ASN GLU PRO HIS SER GLN GLU SER LYS TRP PRO LEU SEQRES 39 B 543 PHE THR THR LYS GLU GLN LYS PHE ILE ASP LEU ASN THR SEQRES 40 B 543 GLU PRO MET LYS VAL HIS GLN ARG LEU ARG VAL GLN MET SEQRES 41 B 543 CYS VAL PHE TRP ASN GLN PHE LEU PRO LYS LEU LEU ASN SEQRES 42 B 543 ALA THR ALA CYS ASP GLY GLU LEU SER SER MODRES 1W75 ASN A 59 ASN GLYCOSYLATION SITE MODRES 1W75 ASN A 416 ASN GLYCOSYLATION SITE MODRES 1W75 ASN B 59 ASN GLYCOSYLATION SITE MODRES 1W75 ASN B 416 ASN GLYCOSYLATION SITE HET NAG A1536 14 HET NAG A1537 14 HET NAG B1536 14 HET NAG B1537 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 7 HOH *252(H2 O) HELIX 1 1A SER A 79 ASN A 85 1 7 HELIX 2 2A GLY A 132 GLU A 139 1 8 HELIX 3 3A VAL A 168 ASN A 183 1 16 HELIX 4 4A SER A 200 LEU A 211 1 12 HELIX 5 5A VAL A 238 LEU A 252 1 15 HELIX 6 6A ASP A 259 GLU A 268 1 10 HELIX 7 7A PRO A 271 GLU A 278 1 8 HELIX 8 8A LEU A 305 SER A 311 1 7 HELIX 9 9A SER A 329 GLY A 335 1 7 HELIX 10 10A ARG A 349 VAL A 360 1 12 HELIX 11 11A ASP A 365 THR A 376 1 12 HELIX 12 12A GLY A 384 TYR A 411 1 28 HELIX 13 13A GLU A 443 PHE A 448 1 6 HELIX 14 14A ALA A 460 THR A 479 1 20 HELIX 15 15A VAL A 518 THR A 535 1 18 SHEET 1 A 3 LEU A 6 THR A 10 0 SHEET 2 A 3 GLY A 13 MET A 16 -1 N VAL A 15 O VAL A 8 SHEET 3 A 3 VAL A 57 ALA A 60 1 N TRP A 58 O LYS A 14 SHEET 1 B11 MET A 16 PRO A 21 0 SHEET 2 B11 HIS A 26 PRO A 34 -1 O ALA A 29 N THR A 18 SHEET 3 B11 TYR A 96 PRO A 102 -1 N ILE A 99 O PHE A 30 SHEET 4 B11 VAL A 142 SER A 147 -1 N LEU A 143 O TRP A 100 SHEET 5 B11 THR A 109 TYR A 116 1 N MET A 112 O VAL A 142 SHEET 6 B11 THR A 193 GLU A 199 1 O THR A 195 N VAL A 113 SHEET 7 B11 ARG A 220 SER A 226 1 N ILE A 223 O ILE A 196 SHEET 8 B11 GLN A 318 ASN A 324 1 N GLY A 322 O LEU A 224 SHEET 9 B11 GLY A 417 PHE A 423 1 N TYR A 421 O LEU A 321 SHEET 10 B11 PHE A 502 LEU A 505 1 N ILE A 503 O LEU A 420 SHEET 11 B11 MET A 510 GLN A 514 -1 N HIS A 513 O PHE A 502 SSBOND 1 CYS A 67 CYS A 94 1555 1555 2.03 SSBOND 2 CYS A 254 CYS A 265 1555 1555 2.04 SSBOND 3 CYS A 402 CYS A 521 1555 1555 2.02 SSBOND 4 CYS B 67 CYS B 94 1555 1555 2.07 SSBOND 5 CYS B 254 CYS B 265 1555 1555 2.03 SSBOND 6 CYS B 402 CYS B 521 1555 1555 2.04 LINK ND2 ASN A 59 C1 NAG A1536 1555 1555 1.46 LINK ND2 ASN A 416 C1 NAG A1537 1555 1555 1.46 LINK ND2 ASN B 59 C1 NAG B1536 1555 1555 1.46 LINK ND2 ASN B 416 C1 NAG B1537 1555 1555 1.45 CISPEP 1 SER A 103 PRO A 104 0 6.76 CISPEP 2 SER B 103 PRO B 104 0 8.71 CRYST1 91.502 106.586 150.343 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010929 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009382 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006651 0.00000 MTRIX1 1 -0.999920 -0.011430 -0.004850 183.61348 1 MTRIX2 1 -0.011550 0.999620 0.025210 -0.44452 1 MTRIX3 1 0.004560 0.025270 -0.999670 101.03433 1